ClinicalTrials.govpublic full text
MS-275 and Azacitidine in Treating Patients With Myelodysplastic Syndromes, Chronic Myelomonocytic Leukemia, or Acute Myeloid Leukemia
acute myeloid leukemia, chronic myelomonocytic leukemia, de novo myelodysplastic syndrome, leukemia, myelodysplastic syndrome, recurrent adult acute myeloid leukemia, secondary acute myeloid leukemia, secondary myelodysplastic syndrome, interventional, phase1
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 917986
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.